Literature DB >> 6211204

Potentiation of fibroblast growth by nodular sclerosing Hodgkin's disease cell cultures.

S R Newcom, L O'Rourke.   

Abstract

Cell cultures were established from 8 lymph nodes replaced by nodular sclerosing Hodgkin's disease. Serum-containing and serum-free conditioned media from these cultures potentiated fibroblast growth and were found to be consistently more potent than fibroblast growth factor, 100 ng/ml, every other day. Both a proliferative response and transformation-like growth were observed using BALB/c 3T3 cells, human diploid fibroblasts, and human embryonic fibroblasts as target cells. The Hodgkin's disease growth factor(s) was not produced by fibroblasts or lymphocytes in the Hodgkin's cultures and was most potent when the Hodgkin's cultures had been enriched with Hodgkin's giant cells. Removal of normal macrophages decreased the proliferative activity but did not eliminate it or nonadherent growth of 3T3 cells in agar. Control cultures of 6 nonmalignant lymph nodes, a Lennert's lymphoma, a mixed cellularity Hodgkin's disease lymph node, and a malignant histiocytosis cell line suggested that among lymph node disorders, this feature may be relatively specific for nodular sclerosing Hodgkin's disease.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6211204

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

1.  Heterogeneity of interleukin 1 production in cultured Reed-Sternberg cell lines HDLM-1, HDLM-1d, and KM-H2.

Authors:  S M Hsu; K Krupen; L B Lachman
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

2.  L-428 nodular sclerosing Hodgkin's cell secretes a unique transforming growth factor-beta active at physiologic pH.

Authors:  S R Newcom; M E Kadin; A A Ansari; V Diehl
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

3.  Lack of effect of colony-stimulating factors, interleukins, interferons, and tumor necrosis factor on the growth and differentiation of cultured Reed-Sternberg cells. Comparison with effects of phorbol ester and retinoic acid.

Authors:  S M Hsu; P L Hsu
Journal:  Am J Pathol       Date:  1990-01       Impact factor: 4.307

4.  Tumor necrosis factor alpha and lymphotoxin production in Hodgkin's disease.

Authors:  C Kretschmer; D B Jones; K Morrison; C Schlüter; W Feist; A J Ulmer; J Arnoldi; J Matthes; T Diamantstein; H D Flad
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

5.  Morphological and immunohistochemical studies of Hodgkin's disease in the spleen.

Authors:  M Takeshita; S Falk; J Schwetje; H J Stutte
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

6.  Production of tumor necrosis factor-alpha and lymphotoxin by cells of Hodgkin's neoplastic cell lines HDLM-1 and KM-H2.

Authors:  P L Hsu; S M Hsu
Journal:  Am J Pathol       Date:  1989-10       Impact factor: 4.307

7.  Immunohistochemical evidence of a role for transforming growth factor beta in the pathogenesis of nodular sclerosing Hodgkin's disease.

Authors:  M E Kadin; B A Agnarsson; L R Ellingsworth; S R Newcom
Journal:  Am J Pathol       Date:  1990-06       Impact factor: 4.307

8.  The distribution of fibronectin in lymph nodes infiltrated by Hodgkin's disease. An immunoperoxidase study on paraffin sections.

Authors:  P Möller; H Achtsätter; M Butzengeiger; B Schüle
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

9.  Expression of prostaglandin H synthase (cyclooxygenase) in Hodgkin's mononuclear and Reed-Sternberg cells. Functional resemblance between H-RS cells and histiocytes or interdigitating reticulum cells.

Authors:  S M Hsu; P L Hsu; S S Lo; K K Wu
Journal:  Am J Pathol       Date:  1988-10       Impact factor: 4.307

10.  Production of transforming growth factor-beta activity by Ki-1 positive lymphoma cells and analysis of its role in the regulation of Ki-1 positive lymphoma growth.

Authors:  S R Newcom; M E Kadin; A A Ansari
Journal:  Am J Pathol       Date:  1988-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.